What are the recommended antibiotics for urinary tract infections (UTI) in males?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for UTI in Males

All UTIs in males are considered complicated by definition and require 7-14 days of treatment (14 days when prostatitis cannot be excluded), with mandatory urine culture and susceptibility testing before initiating empiric therapy. 1

Critical First Step: Obtain Urine Culture

  • Urine culture with susceptibility testing is mandatory before starting antibiotics to guide targeted therapy, as male UTIs have a broader microbial spectrum and higher antimicrobial resistance rates than uncomplicated UTIs in women 1
  • Common pathogens include E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1

First-Line Empiric Oral Antibiotics (Pending Culture Results)

For empiric treatment while awaiting culture results, fluoroquinolones are preferred if local resistance is <10%: 1

  • Ciprofloxacin 500-750 mg twice daily for 7 days (minimum duration for males) 1, 2
  • Levofloxacin 750 mg once daily for 5-7 days 1, 2

Alternative oral options when fluoroquinolones cannot be used: 1, 3, 4

  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7-14 days (avoid if local resistance >20%) 1, 5, 4
  • Trimethoprim 200 mg twice daily for 7 days 3, 4
  • Nitrofurantoin 100 mg twice daily for 7 days (though less studied in males) 3, 4

Treatment Duration Specifics

  • Standard duration: 7 days minimum for uncomplicated male UTI 1
  • Extended duration: 14 days when prostatitis cannot be excluded (which is common in males with UTI symptoms) 1
  • Shorter 7-day courses may be considered only when the patient is hemodynamically stable and afebrile for at least 48 hours 1

Parenteral Options for Severe Presentations

If the patient appears systemically ill or has pyelonephritis, initiate IV therapy: 1

  • Ciprofloxacin 400 mg IV twice daily 1
  • Levofloxacin 750 mg IV once daily 1
  • Ceftriaxone 1-2 g IV once daily (higher dose recommended) 1
  • Cefepime 1-2 g IV twice daily 1
  • Piperacillin-tazobactam 2.5-4.5 g IV three times daily 1

Step-Down to Oral Therapy

  • Transition to oral antibiotics when clinically stable and afebrile for 48 hours 1
  • Adjust antibiotic selection based on culture and susceptibility results 1
  • Complete the full 7-14 day course (total duration, not just oral portion) 1

Critical Pitfalls to Avoid

  • Never use amoxicillin or ampicillin empirically due to very high worldwide resistance rates and poor efficacy 3
  • Do not use short 3-5 day courses as recommended for women—males require minimum 7 days 1, 4
  • Do not skip urine culture—this is mandatory in all male UTIs to guide therapy 1, 4
  • Consider prostatitis in all males with UTI symptoms, as this requires 14 days of treatment and fluoroquinolones have better prostatic penetration 1, 4
  • Assess for urethritis as an alternative diagnosis, particularly in younger sexually active males 4

Special Considerations for Multidrug-Resistant Organisms

If patient has risk factors for resistant organisms (recent antibiotics, healthcare exposure, prior resistant isolates): 1, 6

  • Consider broader-spectrum parenteral agents: ceftolozane-tazobactam 1.5 g IV three times daily, ceftazidime-avibactam 2.5 g IV three times daily, or meropenem 1 g IV three times daily 1, 6
  • Aminoglycosides (gentamicin 5 mg/kg IV once daily or amikacin 15 mg/kg IV once daily) are effective alternatives, especially with prior fluoroquinolone resistance 6

Follow-Up

  • Reassess clinical response within 48-72 hours 4
  • Adjust antibiotics based on culture results and clinical response 1
  • If symptoms persist or recur within 2 weeks, repeat urine culture and consider imaging to evaluate for anatomic abnormalities or prostatic involvement 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Complicated Urinary Tract Infections Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.